This is an auto-generated stub page built from atlas entry frontmatter. A richer
hand-crafted page is planned. See the
atlas source
for the full entry including detailed body sections.
antiphospholipid-syndrome
Antiphospholipid Syndrome
Antiphospholipid syndrome (APS) is an autoimmune thrombophilia from anti-B2GPI and antiphospholipid antibodies; thrombosis (DVT, stroke) and obstetric morbidity; triple-positive aPL = highest risk. Indefinite anticoagulation (warfarin INR 2-3); LMWH + aspirin for obstetric APS.
Entry Metadata
| Field | Value |
|---|---|
| ID | antiphospholipid-syndrome |
| Name | Antiphospholipid Syndrome |
| Status | draft |
| Last reviewed | 2026-06-07 |
| Atlas | 01-human |
| Scale | 07-system |
Cross-Atlas Connections
Sources
- Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295-306. · PubMed 16420554
- Barbhaiya M, Zuily S, Naden R, et al. The 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis. 2023;82(10):1258-1270. · PubMed 37643823